NEUROSCIENCE
A study identifies the enzyme zDHHC7 as key in Alzheimer’s. Its inhibition, using an experimental intranasal drug, stopped cognitive decline in mice. This finding opens new avenues to treat the disease, although it requires validation in humans.
The treatment of Alzheimer’s disease is taking small steps. The recommendation for approval in Europe of lecanemab It was a great advance for people with this disease. However, new targets continue to be investigated to stop the progression of the disease.
Session limit reached
- Access to Premium content is open courtesy of the establishment you are in, but right now there are too many users logged in at once. Please try again after a few minutes.
try again
You have exceeded the session limit
- You can only have three sessions started at a time. We have closed the oldest session so you can continue browsing the rest without limits.
Keep browsing
Article for subscribers only
Report a bug
#Nasal #spray #inhibits #key #enzyme #Alzheimers #mice
